Form 4 holding
10%+ Owner
Reneo Pharmaceuticals, Inc.
- Security class
- Class A Common Stock
- Shares / value
- 1,439,674
- Estimated value
- $3,845,369
- Report date
- 04 Oct 2024
- Price
- $2.67
- Ownership
- Direct
ACORN BIOVENTURES, L.P. - 10%+ Owner at OnKure Therapeutics, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- OKUR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by ACORN BIOVENTURES, L.P. since 28 Sep 2025
Reported holdings for ACORN BIOVENTURES, L.P. in OnKure Therapeutics, Inc.
Form 4 holding
10%+ Owner
OnKure Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,709,944
- Estimated value
- $3,163,396
- Report date
- 15 May 2025
- Price
- $1.85
- Ownership
- Direct
Form 4 holding
10%+ Owner
OnKure Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,129,730
- Estimated value
- $2,090,000
- Report date
- 15 May 2025
- Price
- $1.85
- Ownership
- By Acorn Bioventures 2, L.P.
Transaction history for ACORN BIOVENTURES, L.P. in OnKure Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.